Prevalence of Human Papillomavirus Types in Women with Pre-neoplastic and Neoplastic Cervical Lesions in the Federal District of Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 98, Issue 7, 2003, Pages 879-883

  Camara, Geni N L ^a   Cerqueira, Daniela M ^a   Oliveira, Ana P G ^a   Silva, Evandro O ^b   Carvalho, Luciano G S ^c   Martins, Cláudia R F ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b Hospital Regional da Ceilândia   (Brazil)

^c HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

Author keywords

Brazil; Cervical lesion; Genotypes; HPV 58; Human papillomavirus (HPV); Prevalence

Indexed keywords

VIRUS DNA;

ARTICLE; ASIA; BRAZIL; CONTROLLED STUDY; CYTOLOGY; EUROPE; FEMALE; GENE AMPLIFICATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTH AMERICA; SOUTH AND CENTRAL AMERICA; UTERINE CERVICITIS; UTERINE CERVIX TUMOR; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0345731110     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762003000700003     Document Type: Article

References (37)

1. Altschul SF, Madden TL, Schäffer AA, Zhang Z, Miller W, Lipman DJ 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Research 25: 3389-3402.
2. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton DL, Bauer HM, Wheller CM 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence and phylogenetic algorithms. J Infect Dis 170: 1077-1085.
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87: 796-802.
4. Brasil, Ministério da Saúde, Coordenação Nacional de DST e Aids 2001. Available at internet: http://www.aids.gov.Br/ final/dados/DST%20estudos.
5. Brasil, Ministério da Saúde, Instituto Nacional de Câncer 2002. Available at: http://www.inca.gov.br/cancer/epidemiologia/ estimativa2002/brasil.html
6. Broder S 1992. The Bethesda system for reporting cervical/ vaginal cytologic diagnosis-report of the 1991 Bethesda Workshop. JAMA 267: 1892.
7. Cavalcanti SM, Zando LG, Passos MR, Oliveira LH 2000. Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil. J Infect 40: 80-87.
8. Chan PKS, Li WH, Ma WI, Cheung JLK, Cheng AF 1999. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and pre-cancerous lesions. J Med Virol 59: 232-238.
9. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walbooners JMM 1994. Human papillomavirus and invasive cervical cancer in Brazil. Brit J Cancer 69: 114-119.
10. Giuliano AR, Papenfuss M, Abrahamsen M, Denmanc C, de Zapien JG, Henze JLN, Ortega L, de Gala EMB, Stephan J, Feng J, Baldwin S, Garcia F, Hatch K 2001. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers and Prevention 10: 1129-1136.
11. Hagensee ME 1999. Human papillomavirus vaccine. Infect Urol 12: 11-19.
12. Hwang T 1999. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Medical Science 24: 593-599.
13. IARC-International Agency for Research on Cancer 1995. Monographs on the evaluation of the carcinogenic risks to humans, vol. 64. Human papillomavirus. International Agency for Research on Cancer, Lyon.
14. Lai HG, Sun CA, Yu MH, Chen HJ, Liu HS, Chu TY 1999. Favorable clinical outcome of cervical cancers infected with human papillomavirus type 58 and related types. Int J Cancer (Pred Oncol) 84: 553-557.
15. LANL-Los Alamos National Laboratory, US 1997. http://hpv-web.lanl.gov. HPV Sequence Database. HPV Compendium part I, p. 1-7.
16. Lo KWK, Cheung TH, Chung TKH, Wang VW, Poon JS, Li JCB, Lam P, Wong YF 2001. Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers. Gyn Obst Investigation 51: 202-207.
17. Lorenzato F, Ho L, Terry G, Singers A, Santos LC, De Lucena Batista R, Lubambo T 2000. The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 10: 143-150.
18. Lorincz AT, Reid R, Jenson AB, Greenburg MD, Lancaster W, Kurman RJ 1992. Human papillomavirus infection of the cervix. Obst gynecol 79: 328-337.
19. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Mol Diagn Human Cancer Cells 7: 209-214.
20. Mansur CP 2001. Molecular mechanisms of HPV-associated oncogenesis. In JC Sterling, SK Tying (eds), Human Papillomaviruses - Clinical and Scientific Advances, Arnold, London, p. 24-32.
21. Margall N, Matias-Guiu X, Chillon M, Coll P, Nunes MAV, Quilez M, Rabella N, Prats G, Prat J 1993. Detection of human papillomavirus 16 and 18 DNA in epithelial lesions of the lower genital tract by in situ hybridization and polymerase chain reaction: cervical scrapes are not substitutes for biopsies. J Clin Microbiol 31: 924-930.
22. Meyer T, Arndt R, Christophers E 1998. Association of rare papillomavirus types with genital premalignant and malignant lesions. J Infect Dis 178: 252-255.
23. Muñoz N 2000. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19: 1-5.
24. Noronha V, Mello W, Villa LL, Macedo R, Bisi F, Mota R, Sassamoto K, Monteiro T, Linhares A 1999. Human papillomavirus associated with cervix lesions. Rev Soc Bras Med Trop 32: 235-240.
25. Peyton CL, Wheller CM 1994. Identification of five novel human papillomavirus sequences in the New Mexico triethnic population. J Infect Dis 170: 1089-1092.
26. Poljak M, Brencic A, Seme K, Vince A, Marin IJ 1999. Comparative evaluation of first and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J Clin Microbiol 37: 796-797.
27. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GYF, Klein RS, Burck RD 1997. PCR detection of human papillomavirus: comparison between MY9/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35: 1304-1310.
28. Rabelo-Santos SH, Zeferino L, Villa LL, Sobrinho JP, Amaral RG, Magalhães AV 2003. Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiânia, Brazil. Mem Inst Oswaldo Cruz 98: 181-184.
29. Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaak JP, Carbillet JP, Lassable C, Arveux P, Seilles E 1999. Genital human papillomavirus infection among women recruited for cervical cancer screening or for colposcopy determined by hybrid capture II and polymerase chain reaction. Diag Molec Pathol 8: 157-164.
30. Rolón PA, Smith JS, Muñoz N, Kugg SJ, Herrero R, Bosch X, Lamosas F, Meijer CJLM, Walboomers JMM 2000. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 85: 486-491.
31. Sambrook J, Fritsch EF, Maniatis T 1989. Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbour Laboratory Press, New York.
32. Sasagawa T, Basha W, Yanazaki H, Inoue M 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiology Biomarkers & Prevention 10: 45-52.
33. Sherman ME, Schiffman MH, Lorincz AT, Manos MM, Scott DR, Kurman RJ, Kiviat NB, Stoler M, Glass AG, Rush BB 1994. Toward objective quality assurance in cervical cytopathology: correlations of cytopathologic diagnoses with detection of high-risk Human papillomavirus types. Am J Clin Pathol 102: 182-187.
34. Touze A, de Sanjose S, Coursaget P, Almirall MR, Palacio V, Meijer CJL, Kornegay J, Bosch FX 2001. Prevalence of anti-human papillomavirus type 16, 18, 31 and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol 39: 4344-4348.
35. van Muyden RCPA, ter Harmsel BWA, Smedts FMM, Hermans J, Kuijpers JC, Raikhlin NT, Petrov S, Lebedev A, Ramaekers FCS, Trimbos JB, Kleter B, Quint WGV 1999. Detection and typing of Human papillomavirus in cervical carcinomas in Russian women - A prognostic study. Cancer 85: 2011-2016.
36. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco E 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81: 2959-2968.
37. zur Hausen H, Villiers EM 1994. Human papillomaviruses. Annu Rev Microbiol 48: 427-447.